A neuroprotective mechanism of YGY-E in cerebral ischemic injury in rats

CNS Neuroscience and Therapeutics

Volumn 18, Issue 1, 2012, Pages 14-20

  An, Yong Tong ^a   Zhu, Peng ^a   Zhong, Yan ^a   Sheng, Yu Chen ^a   Zhao, Zhen ^a   Min, Yang ^a   Xia, Yu Ye ^a  

^a SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

Author keywords

Apoptosis; Bcl 2; Hypoxia reoxygenation; Stroke; YGY E

Indexed keywords

APIGENIN 7 O BETA DEXTRO GLUCOPYRANOSYL 1 4' O ALPHA RHAMNOPY RANOSIDE; FLAVONOID GLYCOSIDE; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NEUROPROTECTION; NEWBORN; NONHUMAN; RAT; REOXYGENATION; STAINING; SURVIVAL RATE;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; APIGENIN; APOPTOSIS; BRAIN; BRAIN ISCHEMIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCOSIDES; HIPPOCAMPUS; IN SITU NICK-END LABELING; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OXYGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 84856242095     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2011.00277.x     Document Type: Article

References (37)

1. Wang J, Zhuang H, Doré S. Heme oxygenase 2 is neuroprotective against intracerebral hemorrhage. Neurobiol Dis 2006;22:473-476.
2. Wang X, Zhou YS, Kim HP, et al. Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J Biol Chem 2004;279:5237-5243.
3. Saikumar P, Dong Z, Patel Y, et al. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 1998;17:3401-3415.
4. Laderoute K, Webster K. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ Res 1997;80:336-344.
5. Bossenmeyer C, Chihab R, Muller S, et al. Hypoxia/reoxygenation induces apoptosis through biphasic induction of protein synthesis in cultured rat brain neurons. Brain Res 1998;787:107-116.
6. Aleshin A, Sawa Y, Kitagawa-Sakakida S, et al. 150-kDa oxygen-regulated protein attenuates myocardial ischemiäCreperfusion injury in rat heart. J Mol Cell Cardiol 2005;38:517-525.
7. Ho F, Tsang W, Kong S, et al. The critical role of caspases activation in hypoxia/reoxygenation induced apoptosis. Biochem Bioph Res Co 2006;345:1131-1137.
8. Hou Q, Hsu YT. Bax translocates from cytosol to mitochondria in cardiac cells during apoptosis: Development of a GFP-Bax-stable H9c2 cell line for apoptosis analysis. Am J Physiol- Heart C 2005;289:H477-H487.
9. Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996;27:1124-1129.
10. Kirsch JR, Helfaer MA, Lange DG, et al. Evidence for free radical mechanisms of brain injury resulting from ischemia/reperfusion-induced events. J Neurotraum 1992;9:S157-S163.
11. Lei B, Popp S, Capuano-Waters C, et al. Lidocaine attenuates apoptosis in the ischemic penumbra and reduces infarct size after transient focal cerebral ischemia in rats. Neurosci 2004;125:691-701.
12. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-620.
13. Niizuma K, Yoshioka H, Chen H, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. BBA-Mol Basis Dis 2010;1802:92-99.
14. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-1911.
15. Xia YY, Min Y, Zhong Y, et al. The new application of phoenix-tail fern total flavonoids. China, CN 101091728[P]. 2007-12-26.
16. Xia YY, Min Y, Zhong Y, et al. The new application of apigenin-7-O-β-D-glucopyranosyl-4′-O-α-L-rhamnopyranosid. China, CN 101053570 [P]. 2007-10-17.
17. Lezcano N, Bergson C. D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J Neurophysiol 2002;87:2167-2175.
18. Silva RFM, Falcao AS, Fernandes A, et al. Dissociated primary nerve cell cultures as models for assessment of neurotoxicity. Toxicol Lett 2006;163:1-9.
19. Ye J, Li A, Liu Q, et al. Inhibition of mitogen-activated protein kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells. Clin Exp Pharmacol P 2005;32:1042-1048.
20. Hejmadi MV, Dajas-Bailador F, Barns SM, et al. Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes. Mol Cell Neurosci 2003;24:779-786.
21. Hong SS, Gibney GT, Esquilin M, et al. Effect of protein kinases on lactate dehydrogenase activity in cortical neurons during hypoxia. Brain Res 2004;1009:195-202.
22. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989;119:203-210.
23. Laing RJ, Jakubowski J, Laing RW. Middle cerebral artery occlusion without craniectomy in rats. Which method works best Stroke 1993;24:294-297.
24. Nagasawa H, Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 1989;20:1037-1043.
25. Tamura A, Graham DI, McCulloch J, et al. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cerebr Blood F Met 1981;1:53-60.
26. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci 1993;90:7915-7922.
27. Stadtman ER. Protein oxidation and aging. Science 1992;257:1220-1224.
28. Li CY, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Ph 2002;282:C227-C241.
29. Wang JY, Shum AYC, Wang JY. Hypoxia/reoxygenation induces cell injury via different mechanisms in cultured rat cortical neurons and glial cells. Neurosci Lett 2002;322:187-191.
30. Garay M, Gaarde W, Monia BP, et al. Inhibition of hypoxia/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells. Biochem Pharmacol 2000;59:1033-1043.
31. Kang PM, Haunstetter A, Aoki H, et al. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res 2000;87:118-125.
32. Green DR, Reed JC. Mitochondria and apoptosis: Apoptosis. Science 1998;281:1309-1312.
33. Kitagawa K, Matsumoto M, Tsujimoto Y, et al. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 1998;29:2616-2621.
34. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
35. Williams GC, Liu A, Knipp G, et al. Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). Antimicrob Agents Ch 2002;46:3456-3462.
36. del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945-2948.
37. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976.